News & Research

Loading...

Fundswire

Are global equity markets shifting in our favour?

Orbis Investments
19 September 2024

2024 Superconvergence Biorevolution Series: A Blockbuster Gene Therapy?

WisdomTree
19 September 2024

Nvidia leads focus on earnings

Liontrust Asset Management
19 September 2024

The elusive return on AI investment – it exists

Liontrust Asset Management
18 September 2024

Emerging markets: exploding the “risk” myth

abrdn
18 September 2024

UK Growth Trust: a 2024 perspective

Baillie Gifford
18 September 2024

Is this an inflection point for the yen?

Orbis Investments
17 September 2024

Results analysis: Schroder Asian Total Return

Kepler Trust Intelligence
17 September 2024

2024 Superconvergence biorevolution series: Premonitions of AlphaFold 3

WisdomTree
17 September 2024

Two things – one happening NOW and one coming soon

Premier Miton
17 September 2024
Fundswire

Editor's Picks

The perfect portfolio after the Fed’s first cut

19 September 2024

Funds to hold alongside Jupiter India

18 September 2024

Bull or bear: The best way to invest in each market

18 September 2024

FundCalibre’s nine cheapest active equity funds

18 September 2024

The chart showing where to invest after a Fed rate cut (recession or no recession)

17 September 2024

The IA Global funds that have protected investors during the worst market falls

17 September 2024